{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T10:01:39Z","timestamp":1789380099121,"version":"build-2803163510"},"reference-count":31,"publisher":"Oxford University Press (OUP)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,1,15]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>In observational studies, estrogen replacement therapy is associated with decreased cardiovascular disease rates and increased breast cancer rates. Recent evidence suggests that the impact of estrogen use on disease outcomes may vary by body mass. In a prospective study of 290,827 postmenopausal US women with no history of cancer or cardiovascular disease at enrollment in 1982, the authors examined the association between postmenopausal estrogen use and all-cause, coronary heart disease, stroke, all-cancer, and breast cancer death rates and whether these associations differed by body mass. After 12 years of follow-up, results from Cox proportional hazards models showed that all-cause death rates were lower among baseline estrogen users than never users (rate ratio (RR) = 0.82, 95% confidence interval (CI): 0.78, 0.87). The lowest relative risk was found for coronary heart disease (RR = 0.66, 95% CI: 0.58, 0.77). The inverse association between estrogen use and coronary heart disease mortality was strongest for thin women (body mass index &amp;lt;22 kg\/m2) (RR = 0.49, p for interaction = 0.02). Breast cancer mortality did not increase with estrogen use overall, and no increased risk was observed for thin or heavy women. In this population, the reduction in coronary heart disease mortality among estrogen users was greatest for thinner women. Additional studies are needed to confirm or refute these results.<\/jats:p>","DOI":"10.1093\/aje\/153.2.145","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T23:02:40Z","timestamp":1027724560000},"page":"145-152","source":"Crossref","is-referenced-by-count":56,"title":["Effect of Body Mass on the Association between Estrogen Replacement Therapy and Mortality among Elderly US Women"],"prefix":"10.1093","volume":"153","author":[{"given":"Carmen","family":"Rodriguez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia E.","family":"Calle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpa V.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilith M.","family":"Tatham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J.","family":"Jacobs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Thun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,1,15]]},"reference":[{"key":"2024100810175411600_B1","doi-asserted-by":"crossref","unstructured":"Criqui MH, Suarez L, Barrett-Connor E, et al. Postmenopausal estrogen use and mortality. Results from a prospective study in a defined, homogeneous community. Am J Epidemiol\n\u00a01988;128:606\u201314.","DOI":"10.1093\/oxfordjournals.aje.a115008"},{"key":"2024100810175411600_B2","doi-asserted-by":"crossref","unstructured":"Folsom AR, Mink PJ, Sellers TA, et al. Hormonal replacement therapy and morbidity and mortality in a prospective study of postmenopausal women. Am J Public Health\n\u00a01995;85:1128\u201332.","DOI":"10.2105\/AJPH.85.8_Pt_1.1128"},{"key":"2024100810175411600_B3","unstructured":"Petitti DB, Perlman JA, Sidney S. Noncontraceptive estrogens and mortality: long-term follow-up of women in the Walnut Creek Study. Obstet Gynecol\n\u00a01987;70:289\u201393."},{"key":"2024100810175411600_B4","doi-asserted-by":"crossref","unstructured":"Hunt K, Vessey M, McPherson K. Mortality in a cohort of long-term users of hormone replacement therapy: an updated analysis. Br J Obstet Gynecol\n\u00a01990;97:1080\u20136.","DOI":"10.1111\/j.1471-0528.1990.tb02494.x"},{"key":"2024100810175411600_B5","doi-asserted-by":"crossref","unstructured":"Henderson BE, Paganini-Hill A, Ross RK. Decreased mortality in users of estrogen replacement therapy. Arch Intern Med\n\u00a01991;151:75\u20138.","DOI":"10.1001\/archinte.151.1.75"},{"key":"2024100810175411600_B6","doi-asserted-by":"crossref","unstructured":"Schairer C, Adami HO, Hoover R, et al. Cause-specific mortality in women receiving hormone replacement therapy. Epidemiology\n\u00a01997;8:59\u201365.","DOI":"10.1097\/00001648-199701000-00010"},{"key":"2024100810175411600_B7","doi-asserted-by":"crossref","unstructured":"Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med\n\u00a01997;336:1769\u201375.","DOI":"10.1056\/NEJM199706193362501"},{"key":"2024100810175411600_B8","doi-asserted-by":"crossref","unstructured":"Ettinger B, Friedman GD, Bush T, et al. Reduced mortality associated with long-term postmenopausal estrogen therapy. Obstet Gynecol\n\u00a01996;87:6\u201312.","DOI":"10.1016\/0029-7844(95)00358-4"},{"key":"2024100810175411600_B9","doi-asserted-by":"crossref","unstructured":"Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer. Lancet\n\u00a01997;350:1047\u201359.","DOI":"10.1016\/S0140-6736(97)08233-0"},{"key":"2024100810175411600_B10","doi-asserted-by":"crossref","unstructured":"Colditz GA, Hankinson SE, Hunter DJ, et al. The use of estrogens and progestins and the risk of breast cancer in postmenopausal women. N Engl J Med\n\u00a01995;332:1589\u201393.","DOI":"10.1056\/NEJM199506153322401"},{"key":"2024100810175411600_B11","doi-asserted-by":"crossref","unstructured":"Matthews KA, Kuller LH, Wing RR, et al. Prior to use of estrogen replacement therapy, are users healthier than nonusers? Am J Epidemiol\n\u00a01996;143:971\u20138.","DOI":"10.1093\/oxfordjournals.aje.a008678"},{"key":"2024100810175411600_B12","doi-asserted-by":"crossref","unstructured":"Posthuma WF, Westendorp RG, Vandenbroucke JP. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ\n\u00a01994;308:1268\u20139.","DOI":"10.1136\/bmj.308.6939.1268"},{"key":"2024100810175411600_B13","doi-asserted-by":"crossref","unstructured":"Rosenberg L. Hormone replacement therapy: the need for reconsideration. Am J Public Health\n\u00a01993;83:1670\u20133.","DOI":"10.2105\/AJPH.83.12.1670"},{"key":"2024100810175411600_B14","unstructured":"Garfinkel L. Selection, follow-up, and analysis in the American Cancer Society prospective studies. Natl Cancer Inst Mongr\n\u00a01985;67:49\u201352."},{"key":"2024100810175411600_B15","doi-asserted-by":"crossref","unstructured":"Calle EE, Terrell DD. Utility of the National Death Index for ascertainment of mortality among Cancer Prevention Study II participants. Am J Epidemiol\n\u00a01993;137:235\u201341.","DOI":"10.1093\/oxfordjournals.aje.a116664"},{"key":"2024100810175411600_B16","unstructured":"World Health Organization. International classification of diseases. Manual of the international statistical classification of diseases, injuries, and causes of death. Ninth Revision. Geneva, Switzerland: World Health Organization, 1979."},{"key":"2024100810175411600_B17","unstructured":"Cox DR, Oakes D. Analysis of survival data. London, United Kingdom: Chapman & Hall Ltd, 1984."},{"key":"2024100810175411600_B18","doi-asserted-by":"crossref","unstructured":"Thun MJ, Calle EE, Namboodiri MM, et al. Risk factors for fatal colon cancer in a large prospective study. J Natl Cancer Inst\n\u00a01992;84:1491\u2013500.","DOI":"10.1093\/jnci\/84.19.1491"},{"key":"2024100810175411600_B19","unstructured":"Kleinbaum GG, Kupper LL, Morgenstern H. Epidemiologic research: principles and quantitative methods. New York, NY: Van Nostrand Reinhold Co, 1982."},{"key":"2024100810175411600_B20","doi-asserted-by":"crossref","unstructured":"Willis DB, Calle EE, Miracle-McMahill HL, et al. Estrogen replacement therapy and risk of fatal breast cancer in a prospective cohort of postmenopausal women in the United States. Cancer Causes Control\n\u00a01996;7:449\u201357.","DOI":"10.1007\/BF00052671"},{"key":"2024100810175411600_B21","doi-asserted-by":"crossref","unstructured":"Calle EE, Miracle-McMahill HL, Thun MJ, et al. Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women. J Natl Cancer Inst\n\u00a01995;87:517\u201323.","DOI":"10.1093\/jnci\/87.7.517"},{"key":"2024100810175411600_B22","doi-asserted-by":"crossref","unstructured":"Calle EE. Hormone replacement therapy and colorectal cancer: interpreting the evidence. Cancer Causes Control\n\u00a01997;8:127\u20139.","DOI":"10.1023\/A:1018403826168"},{"key":"2024100810175411600_B23","doi-asserted-by":"crossref","unstructured":"Rodriguez C, Calle EE, Coates RJ, et al. Estrogen replacement therapy and fatal ovarian cancer. Am J Epidemiol\n\u00a01995;141:828\u201335.","DOI":"10.1093\/oxfordjournals.aje.a117518"},{"key":"2024100810175411600_B24","doi-asserted-by":"crossref","unstructured":"Barrett-Connor E. Obesity, atherosclerosis, and coronary artery disease. Ann Intern Med\n\u00a01985;103:1010\u201319.","DOI":"10.7326\/0003-4819-103-6-1010"},{"key":"2024100810175411600_B25","doi-asserted-by":"crossref","unstructured":"Thomas HV, Key TJ, Allen DS, et al. Re: Reversal of relation between body mass and endogenous estrogen concentrations with menopausal status. (Letter). J Natl Cancer Inst\n\u00a01997;89:396\u20138.","DOI":"10.1093\/jnci\/89.5.396"},{"key":"2024100810175411600_B26","doi-asserted-by":"crossref","unstructured":"Schairer C, Lubin J, Troisi R, et al. Menopausal estrogen and estrogen-progestin replacement therapy and breast cancer risk. JAMA\n\u00a02000;283:485\u201391.","DOI":"10.1001\/jama.283.4.485"},{"key":"2024100810175411600_B27","doi-asserted-by":"crossref","unstructured":"Sellers TA, Mink PJ, Cerhan JR, et al. The role of hormone replacement therapy in the risk of breast cancer and total mortality in women with a family history of breast cancer. Ann Intern Med\n\u00a01997;127:973\u201380.","DOI":"10.7326\/0003-4819-127-11-199712010-00004"},{"key":"2024100810175411600_B28","doi-asserted-by":"crossref","unstructured":"Holli K, Isola J, Cuzick J. Hormone replacement therapy and biological aggressiveness of breast cancer. (Letter). Lancet\n\u00a01997;350:1704\u20135.","DOI":"10.1016\/S0140-6736(05)64308-5"},{"key":"2024100810175411600_B29","unstructured":"Persson I, Adami HO, Bergstrom R, et al. Survival in women receiving hormone replacement therapy. A record-linkage study of a large population-based cohort. J Clin Epidemiol\n\u00a01990;43:677\u201385."},{"key":"2024100810175411600_B30","doi-asserted-by":"crossref","unstructured":"Hulley S, Grady D, Bush T, et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA\n\u00a01998;280:605\u201313.","DOI":"10.1001\/jama.280.7.605"},{"key":"2024100810175411600_B31","doi-asserted-by":"crossref","unstructured":"Design of the Women's Health Initiative clinical trial and observational study. The Women's Health Initiative Study Group. Control Clin Trials\n\u00a01998;19:61\u2013109.","DOI":"10.1016\/S0197-2456(97)00078-0"}],"container-title":["American Journal of Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/153\/2\/145\/59637316\/aje_153_2_145.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/aje\/article-pdf\/153\/2\/145\/59637316\/aje_153_2_145.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T16:00:13Z","timestamp":1728403213000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/aje\/article\/153\/2\/145\/118397"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1,15]]},"references-count":31,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2001,1,15]]},"published-print":{"date-parts":[[2001,1,15]]}},"URL":"https:\/\/doi.org\/10.1093\/aje\/153.2.145","relation":{},"ISSN":["1476-6256","0002-9262"],"issn-type":[{"value":"1476-6256","type":"electronic"},{"value":"0002-9262","type":"print"}],"subject":[],"published-other":{"date-parts":[[2001,1,15]]},"published":{"date-parts":[[2001,1,15]]}}}